Cincinnati Children's Hospital Medical Center Logo

Wiginton Lab

Loading...

Related Publications

Dusing M, Florence E, and Wiginton D. PDX-1 is Required for Activation In Vivo from a Duodenum-specific Enhancer. J. Biol. Chem. 276: 14434-14442, 2001.

Bates M, Erwin C, Sanford L, Wiginton D, Bezerra J, Schatzman L, Jegga A, Ley-Ebert C, Williams S, Steinbrecher K, Warner B, Cohen M, and Aronow B. Novel Genes and Functional Relationships in the Adult mouse Gastrointestinal Tract Identified by Microarray Analysis. Gastroenterology 122: 1467-1482, 2002.

Dusing M, Florence E, and Wiginton D. High-level Activation by a Duodenum Specific Enhancer Requires Functional GATA Binding Sites.  Am. J. Physiol 284: G1053-G1065, 2003.

Dusing M and Wiginton D. Epithelial Lineages of the Small Intestine have Unique Patterns of GATA Expression.  J. Mol. Hist. 36: 15-24, 2005.

Maier E, Dusing M, and Wiginton D. Cdx binding determines the timing of enhancer activation in postnatal duodenum. J. Biol. Chem. 280: 13195-13202, 2005.